Inflammatory networks and immune surveillance of pancreatic carcinoma
about
KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective TreatmentFrom bench to bedside a comprehensive review of pancreatic cancer immunotherapy.Pancreatic Cancer Metabolism: Breaking It Down to Build It Back UpPerspectives in the treatment of pancreatic adenocarcinomaControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentSpecificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancerPancreatic cancer, treatment options, and GI-4000Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma.Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations.Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy.Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte functionPD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.Kras as a key oncogene and therapeutic target in pancreatic cancerInduction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.Pancreatic cancer, treatment options, and GI-4000.AID-expressing epithelium is protected from oncogenic transformation by an NKG2D surveillance pathway.Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasisSpatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma.Lack of immunoediting in murine pancreatic cancer reversed with neoantigen.Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.Immune infiltrates as predictive markers of survival in pancreatic cancer patients.Immune-based therapies in pancreatic and colorectal cancers and biomarkers of responsiveness.Immune Therapy in GI Malignancies: A Review.Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies.Pancreatic cancer biology and genetics from an evolutionary perspective.Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D.Metabolic Interactions in the Tumor Microenvironment.Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy.The pancreatic cancer microenvironment: an immunologic battleground.Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer.Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer.The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer.Genetics and Biology of Pancreatic Ductal Adenocarcinoma.A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary BiologyKRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic CancerImmunotherapy at Large: The road to personalized cancer vaccinesTargeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer
P2860
Q26751520-AD3298E2-13BB-4462-8EE5-9AA9D86EA3FAQ26765123-C2E796E3-573C-4891-90FA-2035FD01C023Q26780372-B43F7BBC-3F8C-461D-A019-433419CF2DA7Q26797248-D2C32B06-374F-481B-A6B1-FBD5DC91EB72Q26799117-C773BB54-A08C-410C-8D99-91AB68194551Q26853171-E9129DAF-4092-412B-A70B-DC364D04C03BQ28083814-4DDB8680-7684-409C-A133-98C0C10D8AD6Q33560501-6D3E69F9-FF5A-44AE-9D3A-3AC072E98E6DQ33753714-D515C118-5B5F-4679-83AE-BCC7F5B42F00Q33779875-7F521196-0D53-4AAA-A7EC-FCC4624A5A8BQ33820227-17B4025B-0E6A-4505-9094-5484FF6A479FQ34009960-AC1EAEB5-9C8E-4E07-8F3A-6E53EEC3D46AQ34644359-41463262-B01E-46FC-B5ED-92BA2C2AC8C2Q34659332-A5BC322C-CFC8-439D-AF28-19B1153A9E69Q35329190-EC3CF99F-9D30-4165-B7D7-1222CB962EA7Q35887099-CEA75C7E-57ED-4D05-AFFB-1BF89772C69FQ36159467-40DB7072-41AC-45BF-AE27-7624C673B750Q36549751-71393E20-8EBD-4F2F-994E-A87CD3DC1572Q36821138-0F736F7C-D6A8-42DC-B8CD-3D94C254EB1DQ37261700-CB0FEC90-0F8C-4C7B-ABE4-0629D9860DD9Q37617957-9BBAA3BD-53EB-459E-B1CE-E3C718014383Q37741161-396020C7-2606-4318-ABFF-C5615E269968Q38129379-BC35E527-266C-4578-B3B6-DA4D886C40DBQ38249339-C54ED899-4224-4252-8B9A-CC726F121859Q38445709-393853F7-F2CD-49F2-BC3D-49E8D073A7C9Q38608986-9A4C0F42-AE80-4A1F-A12E-6474C7E1A6A2Q38818544-2B2F9314-31D5-4357-A470-A810652A721BQ38904824-877D0901-B8E6-47D7-ABF1-99928BBE04D5Q39008845-962E119E-A24A-4B10-8156-4E5D229E21FBQ39452100-E79B3CC0-913B-47E8-8948-A118E2116F58Q40756221-436DDBCF-13A5-4AB5-A0AD-69608E38D771Q41970901-DFA76718-A532-4120-AEAB-528681A924E9Q42289841-BBD5DB42-8D91-4D2E-8092-8E583C9B5691Q42660198-A271E71F-F906-4960-BD9B-60132B3BCA5BQ49476384-E7899C47-1A7F-4B3A-8257-955AA04E00F6Q54255820-669966DD-7B84-4AC9-8810-941FD020BE56Q54989340-57FABB20-F0A9-470F-91C3-61FA2C88168EQ57072901-D108C05D-BD5E-4EA5-9876-F676C3FA32F0Q57902926-6DE45FC4-2F11-4B49-A24B-F5C032339868Q59136140-0B47B122-331B-4ADD-B539-ABF29DFB940B
P2860
Inflammatory networks and immune surveillance of pancreatic carcinoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inflammatory networks and immune surveillance of pancreatic carcinoma
@ast
Inflammatory networks and immune surveillance of pancreatic carcinoma
@en
Inflammatory networks and immune surveillance of pancreatic carcinoma
@nl
type
label
Inflammatory networks and immune surveillance of pancreatic carcinoma
@ast
Inflammatory networks and immune surveillance of pancreatic carcinoma
@en
Inflammatory networks and immune surveillance of pancreatic carcinoma
@nl
prefLabel
Inflammatory networks and immune surveillance of pancreatic carcinoma
@ast
Inflammatory networks and immune surveillance of pancreatic carcinoma
@en
Inflammatory networks and immune surveillance of pancreatic carcinoma
@nl
P2860
P3181
P1476
Inflammatory networks and immune surveillance of pancreatic carcinoma
@en
P2093
Lauren J Bayne
Robert H Vonderheide
P2860
P3181
P356
10.1016/J.COI.2013.01.006
P407
P577
2013-04-01T00:00:00Z